BE
Bonness Enterprises Portfolio holdings
AUM
$305M
This Quarter Return
+5.61%
1 Year Return
+20.16%
3 Year Return
+82.96%
5 Year Return
+156.72%
10 Year Return
+388.32%
AUM
$199M
AUM Growth
+$199M
(+6.2%)
Cap. Flow
+$2.28M
Cap. Flow
% of AUM
1.15%
Top 10 Holdings %
Top 10 Hldgs %
63.28%
Holding
40
New
1
Increased
3
Reduced
–
Closed
–
Top Buys
| 1 |
GSK
GSK
|
$1.25M |
| 2 |
AT&T
T
|
$463K |
| 3 |
Unilever
UL
|
$357K |
| 4 |
Organon & Co
OGN
|
$210K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Financials | 31.62% |
| 2 | Healthcare | 28.98% |
| 3 | Technology | 24.27% |
| 4 | Industrials | 4.38% |
| 5 | Consumer Staples | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Progressive
PGR
$145B
| $56.2M | 28.32% |
572,608
| – | – |
|
2
Stryker
SYK
$150B
| $17.8M | 8.95% |
68,400
| – | – |
|
3
Microsoft
MSFT
$3.77T
| $12.6M | 6.33% |
46,400
| – | – |
|
4
Apple
AAPL
$3.45T
| $7.53M | 3.79% |
54,940
| – | – |
|
5
Johnson & Johnson
JNJ
$427B
| $6.42M | 3.23% |
38,938
| – | – |
|
6
Thermo Fisher Scientific
TMO
$186B
| $5.75M | 2.9% |
11,400
| – | – |
|
7
Merck
MRK
$210B
| $5.41M | 2.72% |
69,500
| – | – |
|
8
Intel
INTC
$107B
| $4.99M | 2.51% |
88,950
| – | – |
|
9
Nucor
NUE
$34.1B
| $4.54M | 2.29% |
47,350
| – | – |
|
10
Applied Materials
AMAT
$128B
| $4.46M | 2.24% |
31,300
| – | – |
|
|
11
Unilever
UL
$155B
| $4.45M | 2.24% |
76,040
+6,100
| +9% | +$357K |
|
12
Cisco
CSCO
$274B
| $4.39M | 2.21% |
82,900
| – | – |
|
13
IBM
IBM
$227B
| $4.32M | 2.17% |
29,464
| – | – |
|
14
Emerson Electric
EMR
$74.3B
| $4.19M | 2.11% |
43,500
| – | – |
|
15
AbbVie
ABBV
$372B
| $4.12M | 2.08% |
36,600
| – | – |
|
16
Abbott
ABT
$231B
| $3.79M | 1.91% |
32,700
| – | – |
|
17
Marsh & McLennan
MMC
$101B
| $3.63M | 1.83% |
25,800
| – | – |
|
18
Bristol-Myers Squibb
BMY
$96B
| $3.55M | 1.79% |
53,100
| – | – |
|
19
United Parcel Service
UPS
$74.1B
| $3.11M | 1.57% |
14,950
| – | – |
|
20
Pfizer
PFE
$141B
| $3.08M | 1.55% |
78,608
| – | – |
|
21
John Wiley & Sons Class A
WLY
$2.16B
| $2.91M | 1.47% |
48,400
| – | – |
|
22
Agilent Technologies
A
$35.7B
| $2.65M | 1.33% |
17,900
| – | – |
|
|
23
AT&T
T
$209B
| $2.56M | 1.29% |
88,900
+16,100
| +22% | +$463K |
|
|
24
GSK
GSK
$79.9B
| $2.56M | 1.29% |
64,200
+31,400
| +96% | +$1.25M |
|
25
Corning
GLW
$57.4B
| $2.31M | 1.16% |
56,400
| – | – |
|